Minimal clinically important difference in Barthel dyspnoea after pulmonary rehabilitation in patients with Chronic Obstructive Pulmonary Disease

M. Vitacca (Brescia, Italy), A. Malovini (Pavia, Italy), B. Balbi (Novara, Italy), M. Aliani (Bari, Italy), P. Ceriana (Pavia, Italy), A. Spanevello (Varese, Italy), C. Fracchia (Pavia, Italy), M. Maniscalco (Benevento, Italy), G. Corica (Brescia, Italy), N. Ambrosino (Pavia, Italy), M. Paneroni (Brescia, Italy)

Source: Virtual Congress 2020 – Novelties in pulmonary rehabilitation and chronic respiratory care
Session: Novelties in pulmonary rehabilitation and chronic respiratory care
Session type: Oral Presentation
Number: 5178
Disease area: Airway diseases

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Vitacca (Brescia, Italy), A. Malovini (Pavia, Italy), B. Balbi (Novara, Italy), M. Aliani (Bari, Italy), P. Ceriana (Pavia, Italy), A. Spanevello (Varese, Italy), C. Fracchia (Pavia, Italy), M. Maniscalco (Benevento, Italy), G. Corica (Brescia, Italy), N. Ambrosino (Pavia, Italy), M. Paneroni (Brescia, Italy). Minimal clinically important difference in Barthel dyspnoea after pulmonary rehabilitation in patients with Chronic Obstructive Pulmonary Disease. 5178

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pain is associated with balance and gait impairment in people with Chronic Obstructive Pulmonary Disease (COPD).
Source: Virtual Congress 2020 – A fresh look at the spectrum of symptoms in respiratory disease
Year: 2020


Effectiveness of pulmonary rehabilitation initiated after exacerbation of Chronic Obstructive Pulmonary Disease
Source: International Congress 2018 – Aspects of pulmonary rehabilitation and chronic care
Year: 2018

“Asthma-like features” in Chronic Obstructive Pulmonary Disease (COPD) patients
Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS)
Year: 2018

Gait speed is associated with physical activity in patients with Chronic Obstructive Pulmonary Disease
Source: International Congress 2019 – Breathing, posture and physical activity in respiratory disease patients
Year: 2019


Dysfunctional breathing impacts symptom burden in Chronic Obstructive Pulmonary Disease (COPD).
Source: Virtual Congress 2020 – Air pollution and comorbidities
Year: 2020


Adaptive capacities and complexity of heart rate variability in patients with Chronic Obstructive Pulmonary Disease throughout pulmonary rehabilitation
Source: Virtual Congress 2021 – Pulmonary rehabilitation in clinical conditions
Year: 2021


Role of eosinopenia in predicting mortality and morbidity in patients with Chronic Obstructive Pulmonary Disease (COPD)
Source: International Congress 2019 – Airway diseases and blood cells
Year: 2019


Sexuality in Chronic Obstructive Pulmonary Disease (SEXY COPD)
Source: Virtual Congress 2020 – Comprehensive care and pulmonary rehabilitation for chronic respiratory diseases
Year: 2020

Chronic Obstructive Pulmonary Disease (COPD)
Source: Eur Respir Rev 2009; 18: 133
Year: 2009


Impact of abnormal body water distribution on prognostic of Chronic Obstructive Pulmonary Disease and heart failure patients.
Source: Virtual Congress 2020 – Comorbidities/multimorbidites and mortality in patients with chronic lung diseases
Year: 2020

Upper Respiratory Symptoms in Patients with Chronic Obstructive Pulmonary Disease
Source: Virtual Congress 2020 – Clinical characteristics and diagnostic tools for phenotyping asthma and COPD
Year: 2020


Predictive factors for readmission of patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease and respiratory failure
Source: Respiratory Failure and Mechanical Ventilation Conference 2020
Year: 2020



The role of Microalbuminuria as a predictor marker during acute exacerbations of Chronic Obstructive Pulmonary Disease
Source: Virtual Congress 2021 – Biomarkers for the management of bronchial obstructive diseases
Year: 2021


The DisEntangling Chronic Obstructive pulmonary Disease Exacerbations clinical trials NETwork (DECODE-NET): rationale and vision
Source: Eur Respir J, 56 (1) 2000627; 10.1183/13993003.00627-2020
Year: 2020



Chronic Obstructive Pulmonary Disease Exacerbations
Source: Eur Respir Rev 2009; 18: 305
Year: 2009


Assessment of lung function in symptomatic and asymptomatic smokers without Chronic Obstructive Pulmonary Disease (COPD) using the Impulse Oscillatory Technique (IOT)
Source: Virtual Congress 2020 – Health effects of inhaled nicotine devices: from smoking to vaping and heated tobacco
Year: 2020


The Effects Of Bronchiectasis Severity On Outcomes Of Chronic Obstructive Pulmonary Disease Exacerbation
Source: International Congress 2017 – Imaging markers for COPD and asthma
Year: 2017

Obstructive Sleep Apnoea is a Pulmonary Embolism severity risk factor.
Source: International Congress 2017 – Risk factors: symptomatology and diagnostic approaches for obstructive sleep apnoea
Year: 2017

Cognitive impairment in patients with Idiopathic Pulmonary Fibrosis - Obstructive Sleep Apnea Overlap
Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis
Year: 2019

Pneumonia in Chronic Obstructive Pulmonary Disease (COPD) - is it a separate entity?
Source: International Congress 2018 – COPD exacerbations and bronchiectasis
Year: 2018